Related Experiment Video
Updated: Jun 3, 2026

A Neonatal Mouse Spinal Cord Compression Injury Model
Published on: March 27, 2016
Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone
Lars Garten1, Petra Degenhardt, Christoph Bührer
1Department of Neonatology, Charité University Medical Center, Berlin, Germany. lars.garten@charite.de
Insights
Methylnaltrexone effectively treated postoperative ileus in a neonate receiving opioid analgesia. This peripheral-acting μ-opioid receptor antagonist rapidly resolved intestinal dysmotility without causing pain or withdrawal symptoms.
Area of Science:
- Neonatal care
- Pharmacology
- Gastroenterology
Background:
- Opioid analgesia is frequently used in neonates but can cause significant gastrointestinal side effects, such as ileus.
- Methylnaltrexone, a peripherally acting μ-opioid receptor antagonist, has shown efficacy in adults for opioid-induced constipation and postoperative ileus.
Observation:
- A newborn infant experienced severe, prolonged postoperative ileus despite fentanyl analgesia following major abdominal surgery.
- Bowel function remained quiescent for 8 days, indicating significant intestinal dysmotility.
Findings:
- Intravenous administration of methylnaltrexone (0.15 mg/kg) resulted in rapid resolution of intestinal dysmotility within 15 minutes.
- Daily methylnaltrexone treatments were continued until fentanyl analgesia was discontinued.
- No adverse effects, including pain or opioid withdrawal, were observed during methylnaltrexone treatment.
Implications:
- Methylnaltrexone represents a potential therapeutic option for managing opioid-induced gastrointestinal dysmotility in neonates.
- This case suggests methylnaltrexone can safely and effectively reverse ileus in critically ill newborns undergoing surgery and receiving opioid therapy.
- Further research is warranted to establish optimal dosing and long-term safety of methylnaltrexone in the neonatal population.
Abstract:
Transient impairment of bowel function is a frequent and distressing problem in neonates on opioid-induced analgesia. Methylnaltrexone, a peripheral-acting μ-opioid receptor antagonist, has been studied in adults for the treatment of opioid-induced constipation in advanced illness and has been suggested as a promising therapeutic concept for reducing postoperative ileus. Here, we report on a newborn infant on fentanyl analgesia after major abdominal surgery with aggravated ileus. After 8 days of quiescent bowel, the patient's intestinal dysmotility resolved within 15 minutes after intravenous administration of methylnaltrexone (0.15 mg/kg body weight). Methylnatrexone was repeated daily until cessation of fentanyl administration. There were no signs of pain or opioid withdrawal.
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs for Treatment of Constipation-Predominant IBS
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Parenteral Anesthetics: Overview

